RxSight, Inc.
RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enab…
Medical - Devices
US, Aliso Viejo [HQ]
Financials
Analysts
Wall Street · Earnings · Institutional SentimentA comprehensive analysis section that covers unveiling insights about RxSight, Inc.'s gradings, price targets and earnings estimates. None
| FY | EPS | Revenue [mil.] | Profit [mil.] | EBITDA [mil.] | EBIT [mil.] | Expenses · SGA [mil.] | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| E | E | E | E | E | E | |||||||
| 2021 | - | -2.663 | - | 22 | - | -91 | - | -19 | - | -20 | - | 49 |
| 2022 | -1.7800 | -2.608 | 22 | 48 | -48 | -89 | -41 | -4 | -52 | -4 | 32 | 110 |
| 2023 | -2.4100 | -1.531 | 49 | 88 | -66 | -52 | -57 | -8 | -63 | -8 | 58 | 200 |
| 2024 | - | -0.722 | - | 140 | - | -30 | - | -12 | - | -14 | - | 316 |
| 2025 | - | -0.391 | - | 187 | - | -15 | - | -17 | - | -19 | - | 423 |
| 2026 | - | 2.F5X/td> | - | 2.F5X/td> | - | 2.F5X/td> | - | 2.F51/td> | - | 2.F51 | - | 2.F51 |
| 2027 | - | 1.F6X/td> | - | 1.F6X/td> | - | 1.F6X/td> | - | 1.F61/td> | - | 1.F61 | - | 1.F61 |
| 2028 | - | 0.F7X/td> | - | 0.F7X/td> | - | 0.F7X/td> | - | 0.F71/td> | - | 0.F71 | - | 0.F71 |